Stonebridge Capital Advisors LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 56 filers reported holding NEOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Stonebridge Capital Advisors LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$5,000
-37.5%
7,000
-30.0%
0.00%
-50.0%
Q1 2020$8,000
-46.7%
10,0000.0%0.00%0.0%
Q4 2019$15,0000.0%10,0000.0%0.00%
-33.3%
Q3 2019$15,00010,0000.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders